Effect of pituitary-dependent hypercortisolism on the survival of dogs treated with radiotherapy for pituitary macroadenomas
Journal of Veterinary Internal Medicine · 2023-07-01 · 37 (4) · 1331-1340
DOI: 10.1111/jvim.16724 ↗At a glance
Journal article in Journal of Veterinary Internal Medicine, published online on 2023-07-01. Written by Sofia Rapastella and 7 co-authors. Institution: Anderson Moores Veterinary Specialists, part of Linnaeus Veterinary Limited, The Granary, Winchester, UK. Major MEDLINE topics: Pituitary Neoplasms, Cushing Syndrome, Pituitary ACTH Hypersecretion, Adrenocortical Hyperfunction. Cited 11 times so far (Crossref); 37 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Linnaeus Veterinary Limited supported the costs of the open access publication charges..
Abstract (original language)
Background
Radiotherapy (RT) is an effective treatment for dogs presented with neurologic signs caused by pituitary tumors. However, its impact on the outcome of concurrent pituitary-dependent hypercortisolism (PDH) is controversial.
Objectives
Determine whether dogs with PDH have longer survival after pituitary RT compared with dogs with nonhormonally active pituitary masses and to evaluate whether clinical, imaging, and RT variables affect survival. Animals Ninety-four dogs divided into 2 groups: PDH and non-PDH, based on the presence of hypercortisolism. Forty-seven dogs were allocated to the PDH group and 47 to the non-PDH group.
Methods
Retrospective cohort study in which clinical records of dogs undergoing RT for pituitary macroadenomas between 2008 and 2018 at 5 referral centers were retrospectively evaluated.
Results
Survival was not statistically different between PDH and non-PDH groups (median survival time [MST], 590 days; 95% confidence interval [CI], 0-830 days and 738 days; 95% CI, 373-1103 days, respectively; P = .4). A definitive RT protocol was statistically associated with longer survival compared with a palliative protocol (MST 605 vs 262 days, P = .05). The only factor statistically associated with survival from multivariate Cox proportional hazard analysis was total radiation dose (Gy) delivered (P < .01). Conclusions and Clinical Importance No statistical difference in survival was identified between the PDH and non-PDH groups, and longer survival was associated with higher Gy delivered.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Anderson Moores Veterinary Specialists, part of Linnaeus Veterinary Limited, The Granary, Winchester, UK.
- Anicura Ospedale Veterinario I Portoni Rossi, Bologna, Italy.
- VetCT - Teleconsulting Hospital, St John's Innovation Centre Cowley Rd Cambridge, Cambridge, UK.
- Oncovet, Villeneuve d'Ascq, France.
- University of Cambridge Ringgold standard institution - Veterinary Oncology, Cambridge, UK.
- University of Glasgow School of Veterinary Medicine Ringgold standard institution - Small Animal Hospital, Glasgow, UK.
ORCID profiles: Sofia Rapastella, Simona Morabito, Mellora Sharman
Funding
- Linnaeus Veterinary Limited supported the costs of the open access publication charges.
Cite
APA
Rapastella, S., Morabito, S., Sharman, M., Benoit, J., Schiavo, L., Morris, J., Dobson, J. M., & Scudder, C. J. (2023). Effect of pituitary-dependent hypercortisolism on the survival of dogs treated with radiotherapy for pituitary macroadenomas. Journal of Veterinary Internal Medicine, 37(4), 1331-1340. https://doi.org/10.1111/jvim.16724
Vancouver
Rapastella S, Morabito S, Sharman M, Benoit J, Schiavo L, Morris J, et al. Effect of pituitary-dependent hypercortisolism on the survival of dogs treated with radiotherapy for pituitary macroadenomas. Journal of Veterinary Internal Medicine. 2023;37(4):1331-1340. doi:10.1111/jvim.16724
BibTeX
@article{Rapastella2023,
author = {Rapastella, Sofia and Morabito, Simona and Sharman, Mellora and Benoit, Jérôme and Schiavo, Luca and Morris, Joanna and Dobson, Jane Margaret and Scudder, Christopher John},
title = {Effect of pituitary-dependent hypercortisolism on the survival of dogs treated with radiotherapy for pituitary macroadenomas},
journal = {Journal of Veterinary Internal Medicine},
year = {2023},
volume = {37},
number = {4},
pages = {1331--1340},
doi = {10.1111/jvim.16724}
}
EUVIMED